open access

Vol 11, No 4 (2018)
Research paper
Published online: 2019-03-11
Get Citation

Blood transfusion service in Poland in 2017

Aleksandra Rosiek, Anna Tomaszewska, Elżbieta Lachert, Jolanta Antoniewicz-Papis, Jolanta Kubis, Ryszard Pogłód, Magdalena Łętowska
Journal of Transfusion Medicine 2018;11(4):113-130.

open access

Vol 11, No 4 (2018)
ORIGINAL PAPERS
Published online: 2019-03-11

Abstract

Background: In this study we evaluated the basic aspects of the activity of the Polish Blood Transfusion Service in 2017. Materials and methods: Retrospective analysis of the 2017 data supplied by the Regional Blood Centers. Results: In 2017, blood and blood components were collected in 21 Polish Regional Blood Centers and 133 local collection sites as well as during 13 189 mobile collections. The overall number of blood donors was estimated at 588 184, the majority of which were non-remunerated donors (587 515– including 36 938 responders to donation appeals), as well as 561 autologous donors. Most frequent were whole blood collections (1 171 302) and least frequent – apheresis granulocyte collections (50 procedures) and RBCs collections (24 procedures). Whole blood donations were performed in local collection sites (45.42%), in Regional Blood Centers (27.97%) and mobile collection sites (26.61%). Most frequently prepared blood components were red blood cell concentrates (RBCs - 1 154 239 units) and fresh frozen plasma (FFP - 1 287 001 units, 22.69% for clinical use). Platelet concentrates (PCs) amounted to 51 472 units from apheresis and 77 671 whole blood-derived. Additional processing methods (leukocyte depletion, irradiation) were more frequently applied to PCs (36.99% leukocyte-depleted, 2.52% irradiated, 55.08% both leukocyte-depleted and irradiated) than to RBCs (12.36% leukocyte-depleted, 0.12% irradiated, 8.4% both leukocyte-depleted and irradiated). The overall percentage of PCs and FFP units subjected to pathogen reduction technologies prior to issue for transfusion were.11.41% and 8% respectively. In 2017 — for a variety of reasons — 14 750 units of whole blood, 28 888 units of RBCs, 52 856 units of FFP and 4 916 of pooled PCs and 1 009 of apheresis PCs were wasted. Conclusions: Our study data may contribute to the assessment of the tendencies observed in Polish blood centers and may serve practical-benchmarking. This in turn may prove beneficial to the transfusion community as a whole.

Abstract

Background: In this study we evaluated the basic aspects of the activity of the Polish Blood Transfusion Service in 2017. Materials and methods: Retrospective analysis of the 2017 data supplied by the Regional Blood Centers. Results: In 2017, blood and blood components were collected in 21 Polish Regional Blood Centers and 133 local collection sites as well as during 13 189 mobile collections. The overall number of blood donors was estimated at 588 184, the majority of which were non-remunerated donors (587 515– including 36 938 responders to donation appeals), as well as 561 autologous donors. Most frequent were whole blood collections (1 171 302) and least frequent – apheresis granulocyte collections (50 procedures) and RBCs collections (24 procedures). Whole blood donations were performed in local collection sites (45.42%), in Regional Blood Centers (27.97%) and mobile collection sites (26.61%). Most frequently prepared blood components were red blood cell concentrates (RBCs - 1 154 239 units) and fresh frozen plasma (FFP - 1 287 001 units, 22.69% for clinical use). Platelet concentrates (PCs) amounted to 51 472 units from apheresis and 77 671 whole blood-derived. Additional processing methods (leukocyte depletion, irradiation) were more frequently applied to PCs (36.99% leukocyte-depleted, 2.52% irradiated, 55.08% both leukocyte-depleted and irradiated) than to RBCs (12.36% leukocyte-depleted, 0.12% irradiated, 8.4% both leukocyte-depleted and irradiated). The overall percentage of PCs and FFP units subjected to pathogen reduction technologies prior to issue for transfusion were.11.41% and 8% respectively. In 2017 — for a variety of reasons — 14 750 units of whole blood, 28 888 units of RBCs, 52 856 units of FFP and 4 916 of pooled PCs and 1 009 of apheresis PCs were wasted. Conclusions: Our study data may contribute to the assessment of the tendencies observed in Polish blood centers and may serve practical-benchmarking. This in turn may prove beneficial to the transfusion community as a whole.
Get Citation

Keywords

blood donors; blood donation; blood components

About this article
Title

Blood transfusion service in Poland in 2017

Journal

Journal of Transfusion Medicine

Issue

Vol 11, No 4 (2018)

Article type

Research paper

Pages

113-130

Published online

2019-03-11

Bibliographic record

Journal of Transfusion Medicine 2018;11(4):113-130.

Keywords

blood donors
blood donation
blood components

Authors

Aleksandra Rosiek
Anna Tomaszewska
Elżbieta Lachert
Jolanta Antoniewicz-Papis
Jolanta Kubis
Ryszard Pogłód
Magdalena Łętowska

References (35)
  1. Ustawa dnia 22 sierpnia 1997 r. o publicznej służbie krwi. (Dz. U. z 2017 r. poz. 1371).
  2. Osselaer JC, Messe N, Hervig T, et al. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment. Transfusion. 2008; 48(6): 1061–1071.
  3. Schlenke P. Pathogen inactivation technologies for cellular blood components: an update. Transfus Med Hemother. 2014; 41(4): 309–325.
  4. Grass JA, Wafa T, Reames A, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood. 1999; 93(9): 3140–3147.
  5. Farmer S, Trentino K, Hofmann A, et al. A Programmatic Approach to Patient Blood Management – Reducing Transfusions and Improving Patient Outcomes. The Open Anesthesiology Journal. 2015; 9(1): 6–16.
  6. van Ho, Koopman MMW, Koffijberg H, et al. Historical time trends in red blood cell usage in the Netherland. International Journal of Clinical Transfusion Medicine. 2016; 4: 67–77.
  7. Ellingson KD, Sapiano MRP, Haass KA, et al. Continued decline in blood collection and transfusion in the United States-2015. Transfusion. 2017; 57 Suppl 2: 1588–1598.
  8. WHO Expert Group. Expert Consensus Statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD). Vox Sang. 2012; 103(4): 337–342.
  9. World Health Organization. Towards Self-Sufficiency in Safe Blood and Blood Products based on Voluntary Non-Remunerated Donation. Global Status 2013.
  10. Główny Urząd Statystyczny, Komitet Redakcyjny. Rocznik demograficzny 2012.
  11. Główny Urząd Statystyczny, Komitet Redakcyjny. Rocznik demograficzny 2017.
  12. Pogłód R, Rosiek A, Grabarczyk P, et al. Charakterystyka podstawowych wskaźników dotyczących krwiodawstwa i krwiolecznictwa w Europie - aktualne wyzwania i działania. Journal of Transfusion Medicine. 2015; 8(2): 60–77.
  13. Rabel PO, Planitzer CB, Farcet MR, et al. Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010. Euro Surveill. 2011; 16(10).
  14. Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009; 49 Suppl 2: 1S–29S.
  15. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect. 2014; 20(10): O595–O596.
  16. Jimenez A, Shaz BH, Bloch EM. Zika Virus and the Blood Supply: What Do We Know? Transfus Med Rev. 2017; 31(1): 1–10.
  17. Vassallo R, Goldman M, Germain M, et al. BEST Collaborative. Preoperative Autologous Blood Donation: Waning Indications in an Era of Improved Blood Safety. Transfus Med Rev. 2015; 29(4): 268–275.
  18. European Directorate for the Quality of Medicines and HealthCare (EDQM). Guide to the preparation, use and quality assurance of blood components: recommendation No. R (95) 15, wyd. ; 19: 2017.
  19. Główny Urząd Statystyczny, Komitet Redakcyjny. Rocznik demograficzny 2015.
  20. Główny Urząd Statystyczny, Komitet Redakcyjny. Rocznik demograficzny 2016.
  21. NICE. Blood transfusion. NICE guideline. Published: 18 November 2015. nice.org.uk/guidance/ng24. [Online] [Zacytowano: 03 03 2016.].
  22. Klein AA, Arnold P, Bingham RM, et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia. 2016; 71(7): 829–842.
  23. Simancas-Racines D, Osorio D, Martí-Carvajal AJ, et al. Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion. Cochrane Database Syst Rev. 2015(12): CD009745.
  24. Heitmiller ES, Hill RB, Marshall CE, et al. Blood wastage reduction using Lean Sigma methodology. Transfusion. 2010; 50(9): 1887–1896.
  25. Osselaer JC, Cazenave JP, Lambermont M, et al. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment. Vox Sang. 2008; 94(4): 315–323.
  26. Apelseth TØ, Bruserud Ø, Wentzel-Larsen T, et al. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion. 2007; 47(4): 653–665.
  27. Rosiek A, Anna To, Lachert E, et al. Działalność jednostek organizacyjnych służby krwi w Polsce w 2016 roku. Journal of Transfusion Medicine. 2017; 10(4): 113-129.
  28. WHA 63.12: Availability, safety and quality of blood products. http://apps.who.int/medicinedocs/documents/s19998en/s19998en.pdf. [Online].
  29. Re: AABB’s Proposed Standards for a Patient Blood Management Program st Edition. www.hematology.org/Advocacy/ASH-Testimony/2014/1996.aspx. [Online].
  30. Leahy MF, Trentino KM, May C, et al. Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. Transfusion. 2017; 57(9): 2189–2196.
  31. Sloan JM, Ballen K. SCT in Jehovah's Witnesses: the bloodless transplant. Bone Marrow Transplant. 2008; 41(10): 837–844.
  32. Al-Nawakil C, Quarre MC, Heshmati F, et al. Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. Br J Haematol. 2013; 161(5): 738–740.
  33. Elemary M, Seghatchian J, Stakiw J, et al. Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - Literature review and local experience. Transfus Apher Sci. 2017; 56(3): 317–321.
  34. Skiba R. Pionierskie przeszczepienie szpiku bez transfuzji krwi we Wrocławiu. https://www.mp.pl/pacjent/hematologia/aktualnosci/190136,pionierskie-przeszczepienie-szpiku-bez-transfuzji-krwi-we-wroclawiu. [Online].
  35. European Commission Directorate - General For Health And Food Safety. Summary of the 2016 Annual Reporting of Serious Adverse Reactions and Events for Tissues and Cells. https://ec.europa.eu/health/sites/health/files/blood_tissues_organs/docs/2016_sare_tc_summary_en.pdf[Online].

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Journal of Transfusion Medicine dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl